share_log

Teladoc Health | 8-K: Teladoc Health Reports Third Quarter 2024 Results

Teladoc Health | 8-K: Teladoc Health Reports Third Quarter 2024 Results

Teladoc Health | 8-K:Teladoc Health 公布2024年第三季度业绩
美股SEC公告 ·  2024/10/31 04:16

Moomoo AI 已提取核心信息

Teladoc Health reported Q3 2024 revenue of $640.5M, down 3% YoY, with net loss narrowing to $33.3M ($0.19 per share) from $57.1M in Q3 2023. The Integrated Care segment revenue grew 2% to $383.7M, while BetterHelp segment declined 10% to $256.8M. Adjusted EBITDA decreased 6% to $83.3M.Operating metrics showed mixed performance with U.S. Integrated Care Members increasing 4% to 93.9M, while BetterHelp paying users declined 13% to 0.398M. The company maintained strong liquidity with cash flow from operations of $110.2M and free cash flow of $79.0M in Q3.For Q4 2024, Teladoc expects Integrated Care segment revenue growth of 0-2.5% with adjusted EBITDA margin of 12.25-13.75%. The company's CEO Chuck Divita noted that 2025 will be an important repositioning year, focusing on strengthening the business and unlocking future growth opportunities.
Teladoc Health reported Q3 2024 revenue of $640.5M, down 3% YoY, with net loss narrowing to $33.3M ($0.19 per share) from $57.1M in Q3 2023. The Integrated Care segment revenue grew 2% to $383.7M, while BetterHelp segment declined 10% to $256.8M. Adjusted EBITDA decreased 6% to $83.3M.Operating metrics showed mixed performance with U.S. Integrated Care Members increasing 4% to 93.9M, while BetterHelp paying users declined 13% to 0.398M. The company maintained strong liquidity with cash flow from operations of $110.2M and free cash flow of $79.0M in Q3.For Q4 2024, Teladoc expects Integrated Care segment revenue growth of 0-2.5% with adjusted EBITDA margin of 12.25-13.75%. The company's CEO Chuck Divita noted that 2025 will be an important repositioning year, focusing on strengthening the business and unlocking future growth opportunities.
Teladoc Health报告2024年第三季度营业收入为64050万,同比下降3%,净亏损从2023年第三季度的5710万收窄至3330万(每股0.19美元)。综合护理部门的营业收入增长2%,达到38370万,而BetterHelp部门下降10%,至25680万。调整后的息税折旧摊销前利润(EBITDA)下降6%,为8330万。运营指标表现各异,美国综合护理会员增加4%,达到9390万,而BetterHelp付费用户下降13%,降至39.8万。公司保持了强劲的流动性,第三季度的营运现金流为11020万,自由现金流为7900万。对于2024年第四季度,Teladoc预计综合护理部门的营业收入增长将在0-2.5%之间,调整后的EBITDA利润率为12.25-13.75%。公司的首席执行官Chuck Divita表示,2025年将是一个重要的重定位年,专注于加强业务并开启未来的增长机会。
Teladoc Health报告2024年第三季度营业收入为64050万,同比下降3%,净亏损从2023年第三季度的5710万收窄至3330万(每股0.19美元)。综合护理部门的营业收入增长2%,达到38370万,而BetterHelp部门下降10%,至25680万。调整后的息税折旧摊销前利润(EBITDA)下降6%,为8330万。运营指标表现各异,美国综合护理会员增加4%,达到9390万,而BetterHelp付费用户下降13%,降至39.8万。公司保持了强劲的流动性,第三季度的营运现金流为11020万,自由现金流为7900万。对于2024年第四季度,Teladoc预计综合护理部门的营业收入增长将在0-2.5%之间,调整后的EBITDA利润率为12.25-13.75%。公司的首席执行官Chuck Divita表示,2025年将是一个重要的重定位年,专注于加强业务并开启未来的增长机会。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息